GSK PLC is a British multinational pharmaceutical and biopharmaceutical company headquartered in Brentford, UK, focused on research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products globally.
GSK PLC's USD 1,250,000,000 2.8% bonds (ISIN: US377372AH03, CUSIP: 377372AH0), issued in the United Kingdom and maturing on March 18, 2023, have reached maturity and been redeemed at 100% of face value, with a minimum trading size of 2,000 and paying semi-annual coupons; the bond was unrated by Standard & Poor's.
|